Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPD1 | P10809 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1924843 | 1.00 | HSPD1 (0.48) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL17845122 | 1.00 | HSPD1 (0.48) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL17845100 | 1.00 | HSPD1 (0.48) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL10793318 | 0.99 | HSPD1 (0.46) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL24530361 | 0.89 | HSPD1 (0.44) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL17845133 | 0.88 | ALDH1A1 (0.48) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL23168543 | 0.87 | HSPD1 (0.42) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL4277990 | 0.87 | BLM (0.49) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL93741 | 0.87 | BLM (0.49) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL28532554 | 0.87 | BLM (0.49) | HSPD1BLMHSPE1MEN1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260026953-A1 | BALLOON DELIVERY SYSTEM FOR THE IMPLANT DEPLOYMENT | UNIV NORTHWESTERN (US) | 2026-01-29 | — | — | US | disclosed |
| US-12447239-B2 | 3D-printed bioresorbable all-polymer composite soft tissue scaffolds | NORTHWESTERN UNIVERSITY (US) | 2025-10-21 | — | — | US | disclosed |
| WO-2025091000-A1 | BIODEGRADABLE NANOCOMPOSITE INK FOR 3D PRINTING RADIOPAQUE SCAFFOLDS | NORTHWESTERN UNIVERSITY (US) | 2025-05-01 | — | — | WO | disclosed |
| US-12214104-B2 | Photo-reactive inks and thermal-curable materials made therefrom | NORTHWESTERN UNIVERSITY (US) | 2025-02-04 | — | — | US | disclosed |
| WO-2024020566-A2 | BALLOON DELIVERY SYSTEM FOR THE IMPLANT DEPLOYMENT | NORTHWESTERN UNIVERSITY (US) | 2024-01-25 | — | — | WO | disclosed |
| US-20240009357-A1 | 3D PRINTING OF BIOMEDICAL IMPLANTS | NORTHWESTERN UNIVERSITY | 2024-01-11 | — | — | US | disclosed |
| US-11850328-B2 | Body temperature-triggered, in situ forming biomaterials and devices | NORTHWESTERN UNIVERSITY (US) | 2023-12-26 | — | — | US | disclosed |
| US-11565026-B2 | 3D printing of biomedical implants | NORTHWESTERN UNIVERSITY (US) | 2023-01-31 | — | — | US | disclosed |
| US-20220133958-A1 | 3D-PRINTED BIORESORBABLE ALL-POLYMER COMPOSITE SOFT TISSUE SCAFFOLDS | NORTHWESTERN UNIVERSITY | 2022-05-05 | — | — | US | disclosed |
| US-20210346576-A1 | 3D PRINTING OF BIOMEDICAL IMPLANTS | NORTHWESTERN UNIVERSITY | 2021-11-11 | — | — | US | disclosed |
| WO-2019055656-A1 | PHOTO-REACTIVE INKS AND THERMAL-CURABLE MATERIALS MADE THEREFROM | NORTHWESTERN UNIVERSITY (US) | 2019-03-21 | — | — | WO | disclosed |
| US-20180236122-A1 | POLYMER METAL-ORGANIC FRAMEWORK COMPOSITES | NORTHWESTERN UNIVERSITY | 2018-08-23 | — | — | US | disclosed |
| US-20180125990-A1 | MATERIALS FOR TISSUE REGENERATION | NORTHWESTERN UNIVERSITY | 2018-05-10 | — | — | US | disclosed |
| US-20180117219-A1 | 3D PRINTING OF BIOMEDICAL IMPLANTS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2018-05-03 | — | — | US | disclosed |
| EP-3294312-A1 | MATERIALS FOR TISSUE REGENERATION | Northwestern University (US) | 2018-03-21 | — | — | EP | disclosed |
| US-20170360992-A1 | THROMBORESISTANT-ANTICOAGULANT EXTRACELLULAR MATRIX | NORTHWESTERN UNIVERSITY | 2017-12-21 | — | — | US | disclosed |
| WO-2016183277-A1 | MATERIALS FOR TISSUE REGENERATION | NORTHWESTERN UNIVERSITY (US) | 2016-11-17 | — | — | WO | disclosed |
| WO-2016176444-A1 | 3D PRINTING OF BIOMEDICAL IMPLANTS | NORTHWESTERN UNIVERSITY (US) | 2016-11-03 | — | — | WO | disclosed |
| WO-2016100846-A1 | THROMBORESISTANT-ANTICOAGULANT EXTRACELLULAR MATRIX | NORTHWESTERN UNIVERSITY (US) | 2016-06-23 | — | — | WO | disclosed |
| WO-2016100847-A2 | POLYMER METAL-ORGANIC FRAMEWORK COMPOSITES | NORTHWESTERN UNIVERSITY (US) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180236122-A1 | POLYMER METAL-ORGANIC FRAMEWORK COMPOSITES | PARN, PUF60, PPIF | HSPD1 1731/4885BLM 2092/4885HSPE1 1464/4885 |
| US-11850328-B2 | Body temperature-triggered, in situ forming biomaterials and devices | BMP2, LRBA, BMP1 | HSPD1 65/4885BLM 357/4885HSPE1 128/4885 |
| US-20260026953-A1 | BALLOON DELIVERY SYSTEM FOR THE IMPLANT DEPLOYMENT | SBDS, SMC3, BAG3 | HSPD1 2596/4885BLM 3145/4885HSPE1 3369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.